No correlations were found between CD22 expression and gender (p > 0.05, p = 1.000), age (p > 0.05, p = 0.592), depth of tumor invasion (p > 0.05, p = 0.137) and clinical stage (p > 0.05, p = 0.546). This evidence concerns the gene CD22 and neoplasm.